Alteplase Tied to Better 90-Day Outcomes With Severe Ischemic Stroke

Intravenous alteplase (IV-tPA) provides long-term benefits in patients with severe ischemic stroke (IS). Among 7,138 patients, 33.2% received IV-tPA and IV-tPA had significant benefit for both in-hospital and 90-day mortality among those with more severe IS.

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ